iShares US Pharmaceuticals ETF
102 hedge funds and large institutions have $321M invested in iShares US Pharmaceuticals ETF in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 43 increasing their positions, 32 reducing their positions, and 23 closing their positions.
34% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 32
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
8.04% less ownership
Funds ownership: 104.24% → 96.2% (-8%)
15% less funds holding
Funds holding: 120 → 102 (-18)
21% less capital invested
Capital invested by funds: $404M → $321M (-$83M)
74% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.8M |
| 2 |
BWM
Braver Wealth Management
Needham,
Massachusetts
|
+$4.94M |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.16M |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$4.12M |
| 5 |
Jane Street
New York
|
+$3.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$19.8M |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$8.4M |
| 3 |
CCMG
Clark Capital Management Group
Philadelphia,
Pennsylvania
|
-$4.22M |
| 4 |
UFF
USA Financial Formulas
Ada,
Michigan
|
-$3.99M |
| 5 |
LPL Financial
San Diego,
California
|
-$3.38M |
IHE Hedge Fund Activity: Q3 2015 in Review
102 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q3 2015, worth a combined $321M — down 21% from $404M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of IHE and 6 opened new positions — a net loss of 17 holders — while 32 trimmed existing stakes and 43 added.
The largest buyer was Susquehanna International Group, adding an estimated $5.8M. The largest seller was Morgan Stanley, cutting an estimated $19.8M.
- 102 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q3 2015, down from 120 in Q2 2015.
- Funds reported $321M of iShares US Pharmaceuticals ETF stock for Q3 2015, down 21% quarter-over-quarter.
- 6 funds opened new iShares US Pharmaceuticals ETF positions in Q3 2015 and 23 closed out, a net change of -17 holders.
- The largest iShares US Pharmaceuticals ETF buyer in Q3 2015 was Susquehanna International Group, an estimated $5.8M added.
- The largest iShares US Pharmaceuticals ETF seller in Q3 2015 was Morgan Stanley, an estimated $19.8M sold.
Based on aggregated 13F filings for Q3 2015.